With the FDA recently approving a revolutionary treatment aimed at helping those with spinal cord injuries, Schneider's ...
Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...
Sanofi ( (SNY) ) has issued an announcement. Sanofi announced that the FDA has granted Breakthrough Therapy designation to tolebrutinib for treating non-relapsing secondary progressive multiple ...
Monroe Carell was a natural fit to offer the new therapy. Its multidisciplinary DMD Clinic, co-directed by Burnette, Soslow ...
Kura Oncology, Inc.'s partnership and promising AML treatment make it a top stock pick with significant upside potential for ...
NEW YORK (WABC) -- A breakthrough is offering good news for cancer patients who lose their hair during chemotherapy. New ...
Scientists have discovered a key protein that helps cancer cells avoid detection by the immune system during a type of ...
The Breakthrough Therapy designation is supported by data from the randomized, open-label phase 2 SOLSTICE trial.